News & Analysis as of August 24, 2025

Controlled Substances

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

NAAG 2025 Presidential Initiative Summit: Building on Opioid Litigation Success to Tackle Evolving Drug Threats

Cozen O'Connor on 8/19/2025

This year’s NAAG Presidential Initiative Summit held August 5-6, 2025 in Portsmouth, NH, was hosted by New Hampshire AG and NAAG President John Formella, brought together state AGs, law enforcement officials, federal...more

DEA Announces Three New Telemedicine Rules

King & Spalding on 1/24/2025

On January 16, 2025, the Drug Enforcement Administration (DEA) announced two final rules and a proposed rule for telemedicine flexibilities. In 2024, the DEA issued a one-year extension of the COVID-era telemedicine...more

Election Implications for Telehealth, Health Equity, AI and Life Sciences

Holland & Knight LLP on 11/21/2024

In 2025, Republicans will hold the majority in both chambers of Congress, and the incoming Trump Administration will preside over the executive branch. For healthcare issues at the intersection of access and equity, this...more

CMS Issues Final 2025 Calendar Year Medicare Physician Fee Schedule Final Rule

King & Spalding on 11/20/2024

On November 1, 2024, CMS issued a rule finalizing changes to Medicare payments under the Physician Fee Schedule (PFS) and other Medicare Part B policies effective on or after January 1, 2025 (the Final Rule). Section 1848 of...more

Health Care Week In Review: COVID-19 PHE Expires, DEA Issues Final Rule

Alston & Bird on 5/15/2023

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5 Results

View per page